NUP98/NSD1-positive AML patients exhibit deleterious phenotypes indicated by the higher leukocytes counts and more myelomonocytic leukemia/monocytic leukemia classification (FAB-M4/M5) morphology [79]. This evidence concerns the gene NSD1 and acute myeloid leukemia.